lactic acid has been researched along with Stomach Neoplasms in 53 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 53-year-old man with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) underwent a gastrectomy." | 7.74 | Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy. ( Fujita, Y; Katsuya, H; Sasano, H; Sasano, N; So, M; Sobue, K, 2007) |
| "A 53-year-old man with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) underwent a gastrectomy." | 3.74 | Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy. ( Fujita, Y; Katsuya, H; Sasano, H; Sasano, N; So, M; Sobue, K, 2007) |
| "Twenty-six patients undergoing gastric cancer surgery were randomly assigned to receive parenteral nutrition (PN) supplemented with a combination of ω-6 and ω-3 fatty acids (Omegaven, 0." | 2.76 | ω-3 Fatty acids have no impact on serum lactate levels after major gastric cancer surgery. ( Caliskan, C; Ersin, S; Firat, O; Gezer, G; Kaya, T; Makay, O; Sozbilen, M; Uyar, M, 2011) |
| "Lactate extensively involves in gastric cancer (GC) progression, such as suppressing immune cells function and facilitating tumor angiogenesis." | 1.91 | Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation. ( Gao, Q; Huang, C; Shen, B; Tao, Z; Wang, D; Wang, M; Wang, Q; Xu, J; Zhang, H; Zhao, Y; Zhou, C; Zhu, W, 2023) |
| "USP4 plays a tumor-promoting role in gastric cancer cells by regulating PKM2." | 1.91 | USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2. ( Chen, D; Chen, Y; Cui, S; Guo, S; Guo, Y; Yuan, M, 2023) |
| "Lactic acid level was detected with L-lactate assay kit." | 1.91 | Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse. ( Du, T; He, Y; Huang, F; Li, W; Pan, Q; Shi, H; Wu, H; Wu, X; Yu, M, 2023) |
| "However, the function of SETD1A in gastric cancer (GC) progression and its role in GC metabolic reprogramming are still largely unknown." | 1.56 | Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer. ( Chai, H; Gu, Y; Wu, J; Xu, X; Yu, J, 2020) |
| "SLC1A3 was found to be overexpressed in gastric cancer, and this overexpression was associated with poor prognosis." | 1.56 | SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway. ( Awaleh Moumin, F; Cai, J; Chen, J; Chen, X; Jia, L; Xu, L, 2020) |
| "Chrysin were well-documented as having significant biological roles particularly cancer chemo-preventive activity." | 1.43 | Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles. ( Dastani-Habashi, M; Mofarrah, M; Mohammadian, F; Pilehvar-Soltanahmadi, Y; Zarghami, N, 2016) |
| "However, the role of MCTs in gastric cancer (GC) is not fully understood." | 1.43 | MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. ( Ahn, SM; Chang, WJ; Cho, JH; Jung, KS; Kang, WK; Kim, HS; Kim, KM; Kim, ST; Kim, SY; Lee, I; Lee, J; Lee, JY; Lee, S; Lim, HY; Lim, SH; Park, JO; Park, SH; Park, YS; Song, HN; Yoo, KH, 2016) |
| "Forty-two patients with gastric or colorectal cancer underwent chemotherapy, including FAM or FOLFOX4 regimens." | 1.42 | Biomarkers for assessing mucosal barrier dysfunction induced by chemotherapy: Identifying a rapid and simple biomarker. ( Kong, W; Li, Y; Liu, F; Ni, X; Ping, X; Shen, J; Wang, J; Yu, B, 2015) |
| "Its promoter was hypermethylated in gastric cancer cell lines (57%, 4/7) and gastric carcinomas (33%, 33/101)." | 1.36 | Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. ( Chan, FK; Cheng, AS; Jin, HC; Lam, EK; Liu, X; Shin, VY; Sung, JJ; Wang, X; Yu, J; Zhang, J, 2010) |
| "administration in peritoneal gastric cancer (MKN45) xenografts." | 1.32 | Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model. ( Inoue, K; Kato, Y; Machida, Y; Michiura, T; Nakai, K; Nakane, Y; Onishi, H; Sato, M; Yamamichi, K, 2004) |
| "A new dosage form of cisplatinum (CDDP), lactic acid oligomer microspheres incorporating cisplatinum (CDDP-ms), is designed to slowly release 70% of contained CDDP." | 1.28 | [Intracavitary microspheres incorporating cisplatinum in the treatment of malignant effusions--clinical trials]. ( Hagiwara, A; Ito, M; Iwamoto, A; Lee, M; Sasabe, T; Takahashi, T; Taniguchi, H; Wada, R; Yamaguchi, T; Yoneyama, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (11.32) | 18.7374 |
| 1990's | 4 (7.55) | 18.2507 |
| 2000's | 4 (7.55) | 29.6817 |
| 2010's | 26 (49.06) | 24.3611 |
| 2020's | 13 (24.53) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Z | 1 |
| Diao, W | 1 |
| Shang, J | 1 |
| Cai, T | 1 |
| Chen, X | 3 |
| Cheng, J | 1 |
| Cheng, Z | 1 |
| Wu, X | 4 |
| Qi, S | 1 |
| Qi, Z | 1 |
| Chen, Y | 2 |
| Hu, L | 1 |
| Lin, H | 1 |
| Yu, H | 1 |
| You, J | 1 |
| Xiao, Y | 1 |
| Yao, W | 1 |
| Lin, M | 1 |
| Huang, W | 1 |
| Li, B | 2 |
| Peng, B | 1 |
| Ma, Q | 1 |
| Zhou, X | 1 |
| Liang, M | 1 |
| Tao, Z | 1 |
| Huang, C | 2 |
| Wang, D | 1 |
| Wang, Q | 1 |
| Gao, Q | 1 |
| Zhang, H | 1 |
| Zhao, Y | 1 |
| Wang, M | 1 |
| Xu, J | 1 |
| Shen, B | 1 |
| Zhou, C | 1 |
| Zhu, W | 1 |
| Lu, J | 2 |
| Zhou, Y | 2 |
| Chen, Z | 3 |
| Jiang, H | 1 |
| Li, J | 5 |
| Dou, G | 1 |
| Guo, Y | 2 |
| Yuan, M | 1 |
| Guo, S | 1 |
| Cui, S | 1 |
| Chen, D | 1 |
| Yu, M | 1 |
| Pan, Q | 1 |
| Li, W | 2 |
| Du, T | 1 |
| Huang, F | 1 |
| Wu, H | 1 |
| He, Y | 1 |
| Shi, H | 1 |
| Sun, L | 2 |
| Zhang, Y | 1 |
| Yang, B | 1 |
| Sun, S | 1 |
| Zhang, P | 1 |
| Luo, Z | 1 |
| Feng, T | 1 |
| Cui, Z | 1 |
| Zhu, T | 1 |
| Li, Y | 2 |
| Qiu, Z | 1 |
| Fan, G | 1 |
| Zhang, L | 4 |
| Li, S | 1 |
| Wu, J | 1 |
| Chai, H | 1 |
| Xu, X | 1 |
| Yu, J | 2 |
| Gu, Y | 1 |
| Xu, L | 1 |
| Chen, J | 1 |
| Jia, L | 1 |
| Awaleh Moumin, F | 1 |
| Cai, J | 1 |
| Jin, Z | 1 |
| Lu, Y | 1 |
| Pan, T | 1 |
| Yu, Z | 1 |
| Hou, J | 1 |
| Wu, A | 1 |
| Yang, Z | 2 |
| Li, C | 1 |
| Yan, M | 1 |
| Yan, C | 1 |
| Zhu, Z | 1 |
| Liu, B | 2 |
| Qiu, W | 1 |
| Su, L | 1 |
| Li, R | 1 |
| Chen, H | 1 |
| Wei, J | 1 |
| Qian, H | 1 |
| Su, S | 1 |
| Shao, J | 1 |
| Wang, L | 1 |
| Qian, X | 1 |
| Ding, X | 1 |
| Liu, J | 1 |
| Liu, T | 1 |
| Ma, Z | 1 |
| Wen, D | 1 |
| Zhu, J | 2 |
| Wang, H | 2 |
| Zhou, R | 1 |
| Xia, J | 1 |
| Yang, X | 1 |
| Pan, C | 1 |
| Huang, N | 1 |
| Shi, M | 1 |
| Bin, J | 1 |
| Liao, Y | 1 |
| Liao, W | 1 |
| Gao, Z | 1 |
| Li, Z | 1 |
| Yan, J | 1 |
| Wang, P | 1 |
| Xin, L | 2 |
| Zhang, HT | 1 |
| Yang, WF | 1 |
| Li, YF | 1 |
| Liu, C | 2 |
| Son, J | 1 |
| Yang, SM | 1 |
| Yi, G | 1 |
| Roh, YJ | 1 |
| Park, H | 1 |
| Park, JM | 1 |
| Choi, MG | 1 |
| Koo, H | 1 |
| Zhu, JM | 1 |
| Quan, XL | 1 |
| Han, SC | 1 |
| Fan, XJ | 1 |
| Li, HM | 1 |
| Liang, SS | 1 |
| Wang, RY | 1 |
| Ji, XN | 1 |
| Vasiliev, AA | 1 |
| Varfolomeev, AE | 1 |
| Volkov, IA | 1 |
| Simonenko, NP | 1 |
| Arsenov, PV | 1 |
| Vlasov, IS | 1 |
| Ivanov, VV | 1 |
| Pislyakov, AV | 1 |
| Lagutin, AS | 1 |
| Jahatspanian, IE | 1 |
| Maeder, T | 1 |
| Lin, D | 1 |
| Li, G | 1 |
| Qin, L | 1 |
| Wen, Z | 1 |
| Wang, J | 2 |
| Sun, X | 1 |
| Gu, J | 1 |
| Li, M | 1 |
| Wu, W | 1 |
| Ding, Q | 2 |
| Yang, J | 2 |
| Weng, H | 1 |
| Bao, R | 1 |
| Shu, Y | 1 |
| Liu, Y | 1 |
| Shen, Y | 1 |
| Shi, X | 1 |
| Ouyang, L | 1 |
| Tian, Y | 1 |
| Chen, F | 1 |
| Zhuang, M | 1 |
| Zhong, C | 1 |
| Peng, J | 1 |
| Wang, X | 2 |
| Huang, Y | 1 |
| Liu, X | 2 |
| Chen, R | 1 |
| Zhao, D | 1 |
| Qiao, L | 1 |
| Kong, W | 1 |
| Ping, X | 1 |
| Shen, J | 1 |
| Ni, X | 1 |
| Liu, F | 1 |
| Yu, B | 1 |
| Tsujimoto, H | 1 |
| Morimoto, Y | 1 |
| Takahata, R | 1 |
| Nomura, S | 1 |
| Yoshida, K | 2 |
| Hiraki, S | 1 |
| Horiguchi, H | 1 |
| Miyazaki, H | 1 |
| Ono, S | 1 |
| Saito, D | 1 |
| Hara, I | 1 |
| Ozeki, E | 1 |
| Yamamoto, J | 1 |
| Hase, K | 1 |
| Caot, JQ | 1 |
| Zeng, F | 1 |
| Cheng, H | 1 |
| Hu, XY | 1 |
| Shao, JH | 1 |
| Mohammadian, F | 1 |
| Pilehvar-Soltanahmadi, Y | 1 |
| Mofarrah, M | 1 |
| Dastani-Habashi, M | 1 |
| Zarghami, N | 1 |
| Allen, E | 1 |
| Miéville, P | 1 |
| Warren, CM | 1 |
| Saghafinia, S | 1 |
| Li, L | 1 |
| Peng, MW | 1 |
| Hanahan, D | 1 |
| Lee, JY | 1 |
| Lee, I | 1 |
| Chang, WJ | 1 |
| Ahn, SM | 1 |
| Lim, SH | 1 |
| Kim, HS | 1 |
| Yoo, KH | 1 |
| Jung, KS | 1 |
| Song, HN | 1 |
| Cho, JH | 1 |
| Kim, SY | 1 |
| Kim, KM | 1 |
| Lee, S | 1 |
| Kim, ST | 1 |
| Park, SH | 1 |
| Lee, J | 1 |
| Park, JO | 1 |
| Park, YS | 1 |
| Lim, HY | 1 |
| Kang, WK | 1 |
| Shi, T | 1 |
| Gu, L | 1 |
| Sun, Y | 1 |
| Wang, S | 1 |
| You, C | 1 |
| Zhang, X | 1 |
| Sun, B | 1 |
| Zhang, J | 1 |
| Lam, EK | 1 |
| Shin, VY | 1 |
| Cheng, AS | 1 |
| Chan, FK | 1 |
| Sung, JJ | 1 |
| Jin, HC | 1 |
| Makay, O | 1 |
| Kaya, T | 1 |
| Firat, O | 1 |
| Sozbilen, M | 1 |
| Caliskan, C | 1 |
| Gezer, G | 1 |
| Uyar, M | 1 |
| Ersin, S | 1 |
| Mosina, LM | 1 |
| Tarasova, TV | 1 |
| Soldatova, EM | 1 |
| Chibisov, SM | 1 |
| Avdeĭkina, OI | 1 |
| Kotliarov, AA | 1 |
| Zhao, H | 1 |
| Qian, W | 1 |
| Li, H | 1 |
| Ye, Z | 1 |
| Zhang, G | 1 |
| Xia, M | 1 |
| Gao, J | 1 |
| Kou, G | 1 |
| Dai, J | 1 |
| Hur, H | 1 |
| Xuan, Y | 1 |
| Kim, YB | 1 |
| Lee, G | 1 |
| Shim, W | 1 |
| Yun, J | 1 |
| Ham, IH | 1 |
| Han, SU | 1 |
| Bonelli, P | 1 |
| Tuccillo, FM | 1 |
| Federico, A | 1 |
| Napolitano, M | 1 |
| Borrelli, A | 1 |
| Melisi, D | 1 |
| Rimoli, MG | 1 |
| Palaia, R | 1 |
| Arra, C | 1 |
| Carinci, F | 1 |
| KRONBERGER, L | 1 |
| Inoue, K | 1 |
| Onishi, H | 1 |
| Kato, Y | 1 |
| Michiura, T | 1 |
| Nakai, K | 1 |
| Sato, M | 1 |
| Yamamichi, K | 1 |
| Machida, Y | 1 |
| Nakane, Y | 1 |
| SHACTER, B | 1 |
| BYRON, RL | 1 |
| SHIMKIN, MB | 1 |
| Sasano, N | 1 |
| Fujita, Y | 1 |
| So, M | 1 |
| Sobue, K | 1 |
| Sasano, H | 1 |
| Katsuya, H | 1 |
| Huang, KH | 2 |
| Liu, JH | 2 |
| Zhu, ZH | 2 |
| Li, XX | 1 |
| Lu, XP | 1 |
| Zhou, SY | 1 |
| Wang, LY | 1 |
| Chen, QK | 1 |
| Min, J | 1 |
| Chen, RF | 1 |
| Armstrong, CP | 1 |
| Dent, DM | 1 |
| Berman, P | 1 |
| Aitken, RJ | 1 |
| Golub, IKh | 1 |
| Kazantsev, FN | 1 |
| Kitamura, K | 1 |
| Takahashi, T | 2 |
| Yamaguchi, T | 2 |
| Hagiwara, A | 2 |
| Taniguchi, H | 2 |
| Tanaka, H | 1 |
| Hashimoto, S | 1 |
| Kanda, T | 1 |
| Sakamoto, M | 1 |
| Kubo, T | 1 |
| Maruyama, Y | 1 |
| Zitzelsberger, M | 1 |
| Jauch, KW | 1 |
| Sirtl, C | 1 |
| Iwamoto, A | 1 |
| Yoneyama, C | 1 |
| Ito, M | 1 |
| Sasabe, T | 1 |
| Lee, M | 1 |
| Wada, R | 1 |
| Gorozhanskaia, EG | 1 |
| Gromova, EG | 1 |
| Sviridova, SP | 1 |
| Takahashi, M | 1 |
2 trials available for lactic acid and Stomach Neoplasms
| Article | Year |
|---|---|
ω-3 Fatty acids have no impact on serum lactate levels after major gastric cancer surgery.
Topics: Digestive System Surgical Procedures; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Humans; In | 2011 |
[Post-aggression metabolism and peridural anesthesia: modification of catabolism by anesthesia procedures?].
Topics: Adult; Aged; Analgesia, Epidural; Anesthesia, Endotracheal; Anesthesia, Epidural; Blood Glucose; Blo | 1990 |
51 other studies available for lactic acid and Stomach Neoplasms
| Article | Year |
|---|---|
Circular RNA circ_0000592 elevates ANXA4 expression via sponging miR-1179 to facilitate tumor progression in gastric cancer.
Topics: Animals; Annexin A4; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glycolysis; Humans; Lactic | 2022 |
[Aloin inhibits lactate-induced proliferation and migration of gastric cancer cells by downregulating HMGB1 expression].
Topics: Cell Line, Tumor; Cell Proliferation; Emodin; Gene Expression Regulation, Neoplastic; HMGB1 Protein; | 2021 |
Serum metabolomic profiling for patients with adenocarcinoma of the esophagogastric junction.
Topics: Adenocarcinoma; Esophagogastric Junction; Glutamic Acid; Humans; Lactic Acid; Metabolomics; Stomach | 2022 |
Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer.
Topics: Animals; Flavonoids; Immunogenic Cell Death; Lactic Acid; Mice; Nanoparticles; Polyglycolic Acid; Po | 2022 |
Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation.
Topics: B7-H1 Antigen; Cell Proliferation; Humans; Lactic Acid; Mesenchymal Stem Cells; Stomach Neoplasms; T | 2023 |
Circ_0000419 acts as a tumor suppressor in gastric cancer development via regulating miR-300/RGMB axis.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glycoly | 2023 |
USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2.
Topics: Cell Proliferation; Glucose; Humans; Lactic Acid; Stomach Neoplasms; Ubiquitin-Specific Proteases | 2023 |
Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse.
Topics: Animals; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Mice; Peroxisome P | 2023 |
Lactylation of METTL16 promotes cuproptosis via m
Topics: Apoptosis; Copper; Humans; Lactic Acid; Methyltransferases; RNA, Messenger; Sirtuin 2; Stomach Neopl | 2023 |
Lactic acid promotes macrophage polarization through MCT-HIF1α signaling in gastric cancer.
Topics: Apoptosis; Cell Proliferation; Cytokines; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic | 2020 |
Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Fermentation; Ge | 2020 |
SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Biomarkers; Cell Line, Tumor; Cell Survival; Cell Transf | 2020 |
The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer.
Topics: Brain-Derived Neurotrophic Factor; Fibroblasts; Humans; Indoles; Lactic Acid; Quinolines; Stomach Ne | 2021 |
Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Dose-Response Relationship, Radiati | 2017 |
miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1.
Topics: Adenosine Triphosphate; Cell Line; Cell Proliferation; Down-Regulation; Glucose; Glucose Transporter | 2017 |
Topics: Adenosine Triphosphate; Aerobiosis; Animals; Cell Line, Tumor; Cell Movement; DNA Topoisomerases, Ty | 2017 |
Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Chemistry, | 2017 |
Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.
Topics: AC133 Antigen; Carbon-Sulfur Lyases; Cell Line, Tumor; Cell Survival; Drug Carriers; Humans; Lactic | 2018 |
Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
Topics: Animals; Cell Line, Tumor; Chlorophyll; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; La | 2018 |
Establishment of a Model of Microencapsulated SGC7901 Human Gastric Carcinoma Cells Cocultured with Tumor-Associated Macrophages.
Topics: Carcinoma; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Glucose; Humans; Lactic Acid; | 2018 |
Reducing Humidity Response of Gas Sensors for Medical Applications: Use of Spark Discharge Synthesis of Metal Oxide Nanoparticles.
Topics: Air; Ammonia; Breath Tests; Fires; Gases; Humans; Humidity; Hydrogen; Lactic Acid; Metal Nanoparticl | 2018 |
Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coated Materials, Biocompatible; Drug Carriers; Humans; La | 2013 |
[Anti-tumor effect of 5-FU-PLLA-CNTs on human gastric carcinoma cell lines in vitro].
Topics: Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Fluorouracil; Humans; Lactic Acid | 2014 |
Carnosine inhibits the proliferation of human gastric cancer SGC-7901 cells through both of the mitochondrial respiration and glycolysis pathways.
Topics: Adenosine Triphosphate; Carnosine; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Cell Surv | 2014 |
Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.
Topics: Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Flavanones; Fluorouracil; Glycolysis; Hum | 2015 |
Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screenin | 2015 |
Biomarkers for assessing mucosal barrier dysfunction induced by chemotherapy: Identifying a rapid and simple biomarker.
Topics: Adult; Aged; Amine Oxidase (Copper-Containing); Antineoplastic Agents; Biomarkers; Citrulline; Color | 2015 |
Theranostic Photosensitive Nanoparticles for Lymph Node Metastasis of Gastric Cancer.
Topics: Adenocarcinoma; Animals; Apoptosis; Cell Proliferation; Coloring Agents; Drug Delivery Systems; Fluo | 2015 |
Evaluation of rMETase-Loaded Stealth PLGA/Liposomes Modified with Anti-CAGE scFV for Treatment of Gastric Carcinoma.
Topics: Animals; Apoptosis; Carbon-Sulfur Lyases; Cell Line, Tumor; Cell Survival; DEAD-box RNA Helicases; D | 2015 |
Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles.
Topics: Cell Line, Tumor; Down-Regulation; Drug Carriers; Flavonoids; Gene Expression Regulation, Neoplastic | 2016 |
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expres | 2016 |
MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; F | 2016 |
Enhanced legumain-recognition and NIR controlled released of cisplatin-indocyanine nanosphere against gastric carcinoma.
Topics: Amino Acid Sequence; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cisplatin; Cyste | 2017 |
Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
Topics: Aged; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; Down-Regulation; | 2010 |
[Parameters of oxidative stress in patients with gastric cancer].
Topics: Aged; Female; Follow-Up Studies; Humans; Lactic Acid; Male; Malondialdehyde; Middle Aged; Neoplasm S | 2011 |
Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Dialysis; Doxorubicin; Drug Delivery S | 2012 |
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Blotting, Western; | 2013 |
Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Human | 2012 |
[Lactic acid determination in gastric carcinoma & its influence on intragastric pH measurement].
Topics: Gastric Juice; Humans; Lactic Acid; Leadership; Stomach Neoplasms | 1959 |
Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model.
Topics: Animals; Floxuridine; Humans; Injections, Intraperitoneal; Lactic Acid; Male; Maximum Tolerated Dose | 2004 |
Effect of intravenous glucose on gastric lactic acid in gastric carcinoma.
Topics: Glucose; Humans; Lactic Acid; Stomach; Stomach Neoplasms | 1949 |
Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy.
Topics: Amides; Anesthesia; Anesthesia, Epidural; Anesthetics, Intravenous; Anesthetics, Local; Blood Gas An | 2007 |
[Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts].
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorour | 2007 |
[Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles].
Topics: Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Cell Line, Tumor; Drug Carriers; F | 2007 |
The relationship between gastric carcinoma and gastric juice lactate (L + D) and lactate dehydrogenase.
Topics: Adult; Aged; Carcinoma; Diagnostic Errors; Female; Gastric Acidity Determination; Gastric Juice; Hum | 1984 |
[Hexokinase and lactate dehydrogenase activity, lactic and pyruvic acid content of erythrocytes and acid-base equilibrium in stomach cancer patients after radical operations].
Topics: Acid-Base Equilibrium; Adult; Aged; Enzyme Activation; Erythrocytes; Gastrectomy; Hexokinase; Humans | 1981 |
Postoperative TPN-induced lactic acidosis.
Topics: Acidosis, Lactic; Humans; Lactates; Lactic Acid; Parenteral Nutrition, Total; Stomach Neoplasms; Thi | 1992 |
[Studies on a slow releasing anticancer agent for prevention of peritoneal recurrence of advanced gastrointestinal carcinomas (clinical study)].
Topics: Delayed-Action Preparations; Duodenal Neoplasms; Fluorouracil; Humans; Infusions, Parenteral; Lactat | 1992 |
[Intracavitary microspheres incorporating cisplatinum in the treatment of malignant effusions--clinical trials].
Topics: Animals; Ascitic Fluid; Cisplatin; Delayed-Action Preparations; Female; Humans; Infusions, Intraveno | 1990 |
[The role of ascorbic acid in the combined preoperative preparation of cancer patients].
Topics: Administration, Oral; Ascorbic Acid; Ascorbic Acid Deficiency; Combined Modality Therapy; Esophageal | 1989 |
[Administration of mitomycin-C with an inactivator].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Drug Therapy, Combination; Humans; Lactates; L | 1985 |